Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Pyridium, AZO Products, AZO Standard Maximum Strength (Show all)
This medication comes as a tablet you take for relief of urinary tract pain, burning, irritation, and discomfort, as well as urgent and frequent urination caused by urinary tract infections, surgery, injury, or examination procedures. It is not an antibiotic; it does not cure infections.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| UTI (Urinary Tract Infection) | 14 | 6 |
|
|
|
|
|
| Bladder problems | 9 | 2 |
|
|
|||
| Other | 6 | 0 | |||||
| UTI symptoms | 5 | 1 |
|
||||
| Interstitial Cystitis | 3 | 1 |
|
||||
| Urinary burning | 1 | 1 |
|
See all 20 patients currently taking Phenazopyridine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Phenazopyridine
| Urine orange color | 4 | |
|---|---|---|
| Dizziness and feeling faint | 1 | |
| urine staining of clothing | 1 |
Frequently reported dosages based on patients currently taking Phenazopyridine. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 14 | ||
| Other | 6 | ||
| Doctor's advice | 2 | ||
| Not indicated | 1 | ||
| Side effects too severe | 1 | ||
| Personal research | 1 | ||
| Did not seem to work | 1 |
Adherence
Taking treatment as prescribed
Adherence of Phenazopyridine
Always |
12 | 92% |
|
|---|---|---|---|
Usually |
1 | 8% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Phenazopyridine
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
0 | 0% |
|
Not at all |
13 | 100% |
|
Cost
Paid out of pocket
Cost of Phenazopyridine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 11% |
|
< $25 |
8 | 89% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.